glp 1 breast pain GLP-1 Agonists Poised to Impact Breast Cancer Care Highlighting 3 ongoing clinical trials

L-carnitine L-tartrate (LCLT) is a highly bioavailable form of L-carnitine bound with L-tartaric acid, identified by CAS number 36687-82-8

The authors concluded that GLP-1 receptor agonists are a safe and effective adjunct treatment for weight reduction in women with PCOS. A 2025 review of human and animal studies concluded that GLP-1 receptor agonists offer a multifaceted approach to PCOS management, with benefits across both metabolic and reproductive domains, including improvements in insulin sensitivity, weight loss, and menstrual regularity, with emerging evidence suggesting possible effects on gut microbiota composition

Kaehler KC, Russo PAJ, Katenkamp D, Kreusch T, Neuber K, Schwarz T, et al

Join us and make this journey the one that sticks

Cell Growth Studies Investigate IGF-1 LR3s role in cellular proliferation and differentiation